Skip to main content
All lobbying filings

NVG, LLC

Lobbying for ACCENDRA HEALTH INC. · Global healthcare solutions company.

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate · $80,000.00 income · posted Jul 20, 2026

Official filing document

 Bills named in this filing 3
 Lobbying activity 2
Medicare/Medicaid

Issues related to electronic prescribing, including clinical data element template for Durable Medical Equipment. Issues related to Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Competitive Bidding Updates and DMEPOS accreditation requirements in DMEPOS Calendar Year 2026 Final Rule. H.R.2902/S.1406 - Supplemental Oxygen Access Reform (SOAR) Act of 2025. S.4037 - Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act.

Budget/Appropriations

Report language for FY2027 Appropriations related to diabetes products and the Competitive Bidding Program.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem